RecruitingNCT06793163

Diagnosis and Allergen Identification of Perioperative Anaphylaxis

Diagnosis and Allergen Identification of Perioperative Anaphylaxis: a Multicenter Prospective Cohort Study


Sponsor

Peking University First Hospital

Enrollment

115 participants

Start Date

Jan 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Perioperative anaphylaxis may lead to fatal respiratory and/or circulatory events, yet both clinical diagnosis and management are challenging. Serum tryptase is an indicator that can provide important retrospective diagnostic value for anaphylaxis. Another key point in perioperative anaphylaxis management is to identify the allergens, and thus avoid re-exposure during later perioperative management. Skin testing is an important way to identify allergens.


Eligibility

Min Age: 2 Years

Inclusion Criteria2

  • Aged 2 years or over;
  • Suspected anaphylaxis in the operating rooms, or history of suspected anaphylaxis in the operating room.

Exclusion Criteria2

  • Refuse to participate;
  • Other conditions that are considered unsuitable for study participation.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

Peking University First Hospital

Beijing, Beijing Municipality, China

Beijing Anorectal Hospital (Beijing Erlong Road Hospital)

Beijing, Beijing Municipality, China

Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, China

Beijing, Beijing Municipality, China

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Peking University First Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06793163


Related Trials